SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0000950133-97-000909
Filing Date
1997-03-21
Accepted
1997-03-21 00:00:00
Documents
9
Period of Report
1996-12-31
SROs
AMEX

Document Format Files

Seq Description Document Type Size
1 NOVAVAX, INC. -- FORM 10-K 10-K 134076
2 CERTIFICATE OF INCORPORATION EX-3.1 34765
3 BY-LAWS OF NOVAVAX, INC. EX-3.2 52052
4 AGREEMENT OF LEASE EX-10.7 119418
5 EMPLOYMENT AGREEMENT EX-10.10 5572
6 NET LOSS PER COMMON SGARE EX-11 1222
7 CONSENT OF COOPERS & LYBRAND LLP EX-23 1165
8 FINANCIAL DATA SCHEDULE EX-27 2002
9 IMPORTANT FACTORS REGARDING FORWARD LOOKING STMTS. EX-99 5491
  Complete submission text file 0000950133-97-000909.txt   358043
Mailing Address 12111 PARKLAWN DR 12111 PARKLAWN DR ROCKVILLE MD 20852
Business Address 8320 GUILFORD RD COLUMBIA MD 21046 3018168160
NOVAVAX INC (Filer) CIK: 0001000694 (see all company filings)

IRS No.: 222816046 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-K | Act: 34 | File No.: 000-26770 | Film No.: 97560954
SIC: 2836 Biological Products, (No Diagnostic Substances)